Health Care & Life Sciences » Pharmaceuticals | High Tech Pharm Co. Ltd.

High Tech Pharm Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
10,455
7,835
6,544
5,280
2,100
Depreciation, Depletion & Amortization
1,084
920
810
685
601
Other Funds
-
-
52
-
-
Funds from Operations
13,259
7,671
8,012
4,916
2,608
Changes in Working Capital
6,851
2,502
4,696
3,468
2,844
Net Operating Cash Flow
6,408
10,173
12,709
1,448
5,452
Capital Expenditures
1,117
9,384
19,520
23,352
11,268
Sale of Fixed Assets & Businesses
-
270
393
411
20
Purchase/Sale of Investments
8,637
279
12,657
9,634
133
Net Investing Cash Flow
9,451
9,105
6,470
13,541
11,386
Cash Dividends Paid - Total
1,418
1,772
1,772
1,063
1,063
Issuance/Reduction of Debt, Net
-
3,109
2,616
-
-
Net Financing Cash Flow
1,418
1,336
4,336
1,063
1,063
Net Change in Cash
4,640
2,959
2,151
12,882
7,067
Free Cash Flow
5,291
788
6,811
21,904
5,816
Other Sources
33
-
-
224
5
Exchange Rate Effect
179
555
249
275
70
Other Uses
-
-
-
458
10

About High Tech Pharm Co.

View Profile
Address
280 Sinnae-ro
Eumseong-gun NC 27663
Korea, Republic Of
Employees -
Website http://www.htpharm.com
Updated 09/14/2018
High Tech Pharm Co., Ltd. engages in the manufacture and distribution of raw materials for injectable antibiotic products. Its products include imipenem, cilastatin sodium, blended imipenem-cilastatin sterile, meropenem, panipenem, and faropenem. The company was founded on September 1, 1998 and is headquartered in Eumseong, South Korea.